We are live on
!
Find out more
NFA
Nuveen Fund Advisors Portfolio holdings
AUM
$239K
1-Year Est. Return
19.32%
This Fund
S&P 500
This Quarter
Est. Return
-14.5%
1 Year Est. Return
+19.32%
3 Year Est. Return
+52.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.3M
AUM Growth
-$33.7M
(-75%)
Cap. Flow
-$30.6M
Cap. Flow
% of AUM
-271.67%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
118
New
–
Increased
–
Reduced
45
Closed
73
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ares Capital
ARCC
|
+$611K |
| 2 |
AstraZeneca
AZN
|
+$595K |
| 3 |
Monster Beverage
MNST
|
+$594K |
| 4 |
ExxonMobil
XOM
|
+$587K |
| 5 |
GSK
GSK
|
+$538K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.77% |
| 2 | Healthcare | 15.32% |
| 3 | Technology | 15.31% |
| 4 | Communication Services | 10.22% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cisco
CSCO
$444B
| $521K | 4.62% |
12,035
-11,625
| -49% | -$532K |
|
2
Amazon
AMZN
$2.51T
| $442K | 3.92% |
5,880
-4,540
| -44% | -$377K |
|
3
Johnson & Johnson
JNJ
$624B
| $423K | 3.75% |
3,275
-2,260
| -41% | -$315K |
|
4
NVIDIA
NVDA
$5.06T
| $415K | 3.68% |
124,440
-72,360
| -37% | -$346K |
|
5
Visa
V
$669B
| $410K | 3.63% |
3,109
-2,450
| -44% | -$338K |
|
|
6
GSK
GSK
$102B
| $409K | 3.63% |
8,562
-10,924
| -56% | -$538K |
|
|
7
Ares Capital
ARCC
$13.4B
| $377K | 3.34% |
24,222
-36,931
| -60% | -$611K |
|
8
Verizon
VZ
$183B
| $369K | 3.27% |
6,569
-7,811
| -54% | -$443K |
|
|
MGP
9
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $362K | 3.21% |
13,714
-15,716
| -53% | -$439K |
|
10
Apple
AAPL
$4.72T
| $326K | 2.89% |
8,256
-6,876
| -45% | -$333K |
|
11
Amgen
AMGN
$201B
| $326K | 2.89% |
1,676
-1,274
| -43% | -$249K |
|
12
Texas Instruments
TXN
$260B
| $318K | 2.82% |
3,361
-649
| -16% | -$62.8K |
|
13
Costco
COST
$411B
| $316K | 2.8% |
1,550
-1,319
| -46% | -$295K |
|
14
Meta Platforms (Facebook)
META
$1.54T
| $314K | 2.78% |
2,392
-2,718
| -53% | -$394K |
|
15
Illumina
ILMN
$29.8B
| $304K | 2.69% |
1,042
-1,119
| -52% | -$347K |
|
16
Boeing
BA
$165B
| $292K | 2.59% |
905
-279
| -24% | -$96.4K |
|
17
Honeywell
HON
$78B
| $291K | 2.58% |
2,336
-2,136
| -48% | -$292K |
|
18
Chevron
CVX
$387B
| $279K | 2.47% |
2,566
-2,213
| -46% | -$256K |
|
|
SCHW
19
Charles Schwab
SCHW
$177B
| $275K | 2.44% |
6,623
-5,898
| -47% | -$267K |
|
20
Procter & Gamble
PG
$342B
| $273K | 2.42% |
2,965
-2,938
| -50% | -$263K |
|
|
RTN
21
DELISTED
Raytheon Company
RTN
| $271K | 2.4% |
1,770
-346
| -16% | -$62K |
|
|
HOLX
22
DELISTED
Hologic
HOLX
| $266K | 2.36% |
6,479
-5,259
| -45% | -$216K |
|
23
3M
MMM
$87.5B
| $266K | 2.36% |
1,667
-1,653
| -50% | -$274K |
|
24
Walt Disney
DIS
$161B
| $262K | 2.32% |
2,391
-468
| -16% | -$53.2K |
|
25
Blackrock
BLK
$161B
| $258K | 2.29% |
657
-544
| -45% | -$223K |
|
Similar funds
PGC
CAM
CCM
LPC
TCM
SGS
ACM
HMPV
Nuveen Fund Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Nuveen Fund Advisors held 118 positions worth $11.3M, down 75% from $45M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Nuveen Fund Advisors withdrew a net $30.6M in Q4 2018, closing 73 positions and reducing 45 holdings. Its most notable exit was AstraZeneca, an estimated $595K position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.
- Nuveen Fund Advisors's biggest Q4 2018 reduction was Ares Capital, cutting an estimated $611K.
- Nuveen Fund Advisors fully exited AstraZeneca in Q4 2018, selling an estimated $595K.
- Nuveen Fund Advisors's ten largest holdings make up 36% of its $11.3M portfolio in Q4 2018.
- Nuveen Fund Advisors opened 0 new positions and closed 73 in Q4 2018.
- Nuveen Fund Advisors's portfolio value fell 75% quarter-over-quarter to $11.3M.
Based on Nuveen Fund Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.